{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:40:05Z","timestamp":1764175205242},"reference-count":44,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,5]]},"DOI":"10.7759\/cureus.24755","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T17:35:16Z","timestamp":1651772116000},"source":"Crossref","is-referenced-by-count":4,"title":["Hidradenitis Suppurativa in the United States: Insights From the National Inpatient Sample (2008-2017) on Contemporary Trends in Demographics, Hospitalization Rates, Chronic Comorbid Conditions, and Mortality"],"prefix":"10.7759","author":[{"given":"Amie","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhanshree","family":"Solanki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uvesh","family":"Mansuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aanandita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purnima","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shantanu","family":"Solanki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2014.07.012","article-title":"Hidradenitis suppurativa","volume":"28","author":"Margesson LJ","year":"2014","unstructured":"Margesson LJ, Danby FW. Hidradenitis suppurativa. Best Pract Res Clin Obstet Gynaecol. 2014, 28:1013-27. 10.1016\/j.bpobgyn.2014.07.012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref2","article-title":"Hidradenitis suppurativa: causes, features, and current treatments","volume":"11","author":"Vinkel C","year":"2018","unstructured":"Vinkel C, Thomsen SF. Hidradenitis suppurativa: causes, features, and current treatments. J Clin Aesthet Dermatol. 2018, 11:17-23.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/jd9.0000000000000161","article-title":"Hidradenitis suppurativa: an exploration of genetic perturbations and immune dysregulation","volume":"4","author":"Preda-Naumescu A","year":"2021","unstructured":"Preda-Naumescu A, Ahmed HN, Mayo TT, Yusuf N. Hidradenitis suppurativa: an exploration of genetic perturbations and immune dysregulation. Int J Dermatol Venereol. 2021, 4:86-93. 10.1097\/jd9.0000000000000161","journal-title":"Int J Dermatol Venereol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00892","article-title":"An integrated approach to unravel hidradenitis suppurativa etiopathogenesis","volume":"10","author":"Tricarico PM","year":"2019","unstructured":"Tricarico PM, Boniotto M, Genovese G, Zouboulis CC, Marzano AV, Crovella S. An integrated approach to unravel hidradenitis suppurativa etiopathogenesis. Front Immunol. 2019, 10:892. 10.3389\/fimmu.2019.00892","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/20406223211055920","article-title":"New perspectives on the treatment of hidradenitis suppurativa","volume":"12","author":"Amat-Samaranch V","year":"2021","unstructured":"Amat-Samaranch V, Agut-Busquet E, Vilarrasa E, Puig L. New perspectives on the treatment of hidradenitis suppurativa. Ther Adv Chronic Dis. 2021, 12:10.1177\/20406223211055920","journal-title":"Ther Adv Chronic Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2021.10.012","article-title":"Clinical considerations in the management of hidradenitis suppurativa in women","volume":"7","author":"Kozera EK","year":"2021","unstructured":"Kozera EK, Lowes MA, Hsiao JL, Frew JW. Clinical considerations in the management of hidradenitis suppurativa in women. Int J Womens Dermatol. 2021, 7:664-71. 10.1016\/j.ijwd.2021.10.012","journal-title":"Int J Womens Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02965","article-title":"Hidradenitis suppurativa: a systematic review integrating inflammatory pathways into a cohesive pathogenic model","volume":"9","author":"Vossen AR","year":"2018","unstructured":"Vossen AR, van der Zee HH, Prens EP. Hidradenitis suppurativa: a systematic review integrating inflammatory pathways into a cohesive pathogenic model. Front Immunol. 2018, 9:2965. 10.3389\/fimmu.2018.02965","journal-title":"Front Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/JCAS.JCAS_80_16","article-title":"The clinical pattern of axillary hidradenitis suppurativa among Saudi Arabians: mode of presentation and treatment challenges","volume":"10","author":"Shirah BH","year":"2017","unstructured":"Shirah BH, Shirah HA. The clinical pattern of axillary hidradenitis suppurativa among Saudi Arabians: mode of presentation and treatment challenges. J Cutan Aesthet Surg. 2017, 10:95-100. 10.4103\/JCAS.JCAS_80_16","journal-title":"J Cutan Aesthet Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.11337.1","article-title":"Hidradenitis suppurativa: an update on connecting the tracts","volume":"6","author":"Smith MK","year":"2017","unstructured":"Smith MK, Nicholson CL, Parks-Miller A, Hamzavi IH. Hidradenitis suppurativa: an update on connecting the tracts. F1000Res. 2017, 6:1272. 10.12688\/f1000research.11337.1","journal-title":"F1000Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.06.1301","article-title":"Evaluating patients' unmet needs in hidradenitis suppurativa: results from the Global Survey Of Impact and Healthcare Needs (VOICE) project","volume":"82","author":"Garg A","year":"2020","unstructured":"Garg A, Neuren E, Cha D, et al.. Evaluating patients' unmet needs in hidradenitis suppurativa: results from the Global Survey Of Impact and Healthcare Needs (VOICE) project. J Am Acad Dermatol. 2020, 82:366-76. 10.1016\/j.jaad.2019.06.1301","journal-title":"J Am Acad Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1082","article-title":"Psychosocial impact of hidradenitis suppurativa: a qualitative study","volume":"91","author":"Esmann S","year":"2011","unstructured":"Esmann S, Jemec GB. Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Derm Venereol. 2011, 91:328-32. 10.2340\/00015555-1082","journal-title":"Acta Derm Venereol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.10.024","article-title":"Profound disturbances of sexual health in patients with acne inversa","volume":"67","author":"Kurek A","year":"2012","unstructured":"Kurek A, Peters EM, Chanwangpong A, Sabat R, Sterry W, Schneider-Burrus S. Profound disturbances of sexual health in patients with acne inversa. J Am Acad Dermatol. 2012, 67:422-8.e1. 10.1016\/j.jaad.2011.10.024","journal-title":"J Am Acad Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.0201","article-title":"Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States","volume":"153","author":"Garg A","year":"2017","unstructured":"Garg A, Kirby JS, Lavian J, Lin G, Strunk A. Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States. JAMA Dermatol. 2017, 153:760-4. 10.1001\/jamadermatol.2017.0201","journal-title":"JAMA Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.09.019","article-title":"Characterizing inpatient hospitalizations for hidradenitis suppurativa in the United States","volume":"82","author":"Anzaldi L","year":"2020","unstructured":"Anzaldi L, Perkins JA, Byrd AS, Kharrazi H, Okoye GA. Characterizing inpatient hospitalizations for hidradenitis suppurativa in the United States. J Am Acad Dermatol. 2020, 82:510-3. 10.1016\/j.jaad.2019.09.019","journal-title":"J Am Acad Dermatol"},{"key":"ref15","unstructured":"Overview of National (Nationwide) Inpatient Sample (NIS). (2020). Accessed. November 7, 2020: https:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp."},{"key":"ref16","unstructured":"NIS database documentation. (2020). Accessed. November 7, 2020: https:\/\/www.hcup-us.ahrq.gov\/db\/nation\/nis\/nisdbdocumentation.jsp."},{"key":"ref17","unstructured":"NIS description of data elements. (2008). Accessed. February 7, 2021: https:\/\/www.hcup-us.ahrq.gov\/db\/vars\/i10_dxn\/nisnote.jsp."},{"key":"ref18","unstructured":"International Statistical Classification of Diseases and Related Health Problems (ICD). (2021). Accessed. February 7, 2021: https:\/\/www.who.int\/standards\/classifications\/classification-of-diseases."},{"key":"ref19","unstructured":"Clinical Classifications Software Refined (CCSR). (2020). Accessed. February 7, 2021: http:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/ccsr\/ccs_refined.jsp."},{"key":"ref20","unstructured":"APRDRG - All Patient Refined DRG. (2008). Accessed. June 5, 2021: http:\/\/www.hcup-us.ahrq.gov\/db\/vars\/aprdrg\/nisnote.jsp."},{"key":"ref21","unstructured":"DUA training - accessible version. (2020). Accessed. March 25, 2020: http:\/\/www.hcup-us.ahrq.gov\/DUA\/dua_508\/DUA508version.jsp."},{"key":"ref22","unstructured":"Trend weights for HCUP NIS data. (2020). Accessed. September 7, 2020: https:\/\/www.hcup-us.ahrq.gov\/db\/nation\/nis\/trendwghts.jsp."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2017.07.044","article-title":"Association of chronic kidney disease with in-hospital outcomes of transcatheter aortic\u00a0valve replacement","volume":"10","author":"Gupta T","year":"2017","unstructured":"Gupta T, Goel K, Kolte D, et al.. Association of chronic kidney disease with in-hospital outcomes of transcatheter aortic\u00a0valve replacement. JACC Cardiovasc Interv. 2017, 10:2050-60. 10.1016\/j.jcin.2017.07.044","journal-title":"JACC Cardiovasc Interv"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/20503121211022996","article-title":"Pulmonary embolism in chronic kidney disease and end-stage renal disease hospitalizations: trends, outcomes, and predictors of mortality in the United States","volume":"9","author":"Singh J","year":"2021","unstructured":"Singh J, Khadka S, Solanki D, et al.. Pulmonary embolism in chronic kidney disease and end-stage renal disease hospitalizations: trends, outcomes, and predictors of mortality in the United States. SAGE Open Med. 2021, 9:10.1177\/20503121211022996","journal-title":"SAGE Open Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.14740\/gr1371","article-title":"Clostridium difficile infection hospitalizations in the United States: insights from the 2017 National Inpatient Sample","volume":"14","author":"Solanki D","year":"2021","unstructured":"Solanki D, Kichloo A, El-Amir Z, Dahiya DS, Singh J, Wani F, Solanki S. Clostridium difficile infection hospitalizations in the United States: insights from the 2017 National Inpatient Sample. Gastroenterology Res. 2021, 14:87-95. 10.14740\/gr1371","journal-title":"Gastroenterology Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1159\/000448515","article-title":"Hospitalisations with hidradenitis suppurativa: an increasing problem that deserves closer attention","volume":"232","author":"Santos JV","year":"2016","unstructured":"Santos JV, Lisboa C, Lanna C, Costa-Pereira A, Freitas A. Hospitalisations with hidradenitis suppurativa: an increasing problem that deserves closer attention. Dermatology. 2016, 232:613-8. 10.1159\/000448515","journal-title":"Dermatology"},{"key":"ref27","article-title":"What is hidradenitis suppurativa?","volume":"63","author":"Lee EY","year":"2017","unstructured":"Lee EY, Alhusayen R, Lansang P, Shear N, Yeung J. What is hidradenitis suppurativa?. Can Fam Physician. 2017, 63:114-20.","journal-title":"Can Fam Physician"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1159\/000439438","article-title":"Diagnoses of hidradenitis suppurativa in the United States, 1979-2012","volume":"1","author":"McMillan K","year":"2016","unstructured":"McMillan K. Diagnoses of hidradenitis suppurativa in the United States, 1979-2012. Skin Appendage Disord. 2016, 1:117-22. 10.1159\/000439438","journal-title":"Skin Appendage Disord"},{"key":"ref29","article-title":"Gender differences in the utilization of health care services","volume":"49","author":"Bertakis KD","year":"2000","unstructured":"Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J Fam Pract. 2000, 49:147-52.","journal-title":"J Fam Pract"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.07.027","article-title":"Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States","volume":"68","author":"Cosmatos I","year":"2013","unstructured":"Cosmatos I, Matcho A, Weinstein R, Montgomery MO, Stang P. Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. J Am Acad Dermatol. 2013, 68:412-9. 10.1016\/j.jaad.2012.07.027","journal-title":"J Am Acad Dermatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1159\/000363381","article-title":"Prevalence of hidradenitis suppurativa: a population-based study in Olmsted County, Minnesota","volume":"229","author":"Shahi V","year":"2014","unstructured":"Shahi V, Alikhan A, Vazquez BG, Weaver AL, Davis MD. Prevalence of hidradenitis suppurativa: a population-based study in Olmsted County, Minnesota. Dermatology. 2014, 229:154-8. 10.1159\/000363381","journal-title":"Dermatology"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2020.02.005","article-title":"Special considerations for women with hidradenitis suppurativa","volume":"6","author":"Collier E","year":"2020","unstructured":"Collier E, Shi VY, Parvataneni RK, Lowes MA, Hsiao JL. Special considerations for women with hidradenitis suppurativa. Int J Womens Dermatol. 2020, 6:85-8. 10.1016\/j.ijwd.2020.02.005","journal-title":"Int J Womens Dermatol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1159\/000486741","article-title":"Hidradenitis suppurativa: disease burden and etiology in skin of color","volume":"233","author":"Lee DE","year":"2017","unstructured":"Lee DE, Clark AK, Shi VY. Hidradenitis suppurativa: disease burden and etiology in skin of color. Dermatology. 2017, 233:456-61. 10.1159\/000486741","journal-title":"Dermatology"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1177\/1203475420972348","article-title":"Race-specific prevalence of hidradenitis suppurativa","volume":"25","author":"Sachdeva M","year":"2021","unstructured":"Sachdeva M, Shah M, Alavi A. Race-specific prevalence of hidradenitis suppurativa. J Cutan Med Surg. 2021, 25:177-87. 10.1177\/1203475420972348","journal-title":"J Cutan Med Surg"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.2117","article-title":"Association of low socioeconomic status with hidradenitis suppurativa in the United States","volume":"154","author":"Wertenteil S","year":"2018","unstructured":"Wertenteil S, Strunk A, Garg A. Association of low socioeconomic status with hidradenitis suppurativa in the United States. JAMA Dermatol. 2018, 154:1086-8. 10.1001\/jamadermatol.2018.2117","journal-title":"JAMA Dermatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1159\/000505149","article-title":"Clinical pearls for managing hidradenitis suppurativa patients of low socioeconomic status","volume":"236","author":"McKenzie SA","year":"2020","unstructured":"McKenzie SA, Lev-Tov HA, Shi VY, Hsiao JL. Clinical pearls for managing hidradenitis suppurativa patients of low socioeconomic status. Dermatology. 2020, 236:439-44. 10.1159\/000505149","journal-title":"Dermatology"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-030579","article-title":"Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data","volume":"9","author":"Marvel J","year":"2019","unstructured":"Marvel J, Vlahiotis A, Sainski-Nguyen A, Willson T, Kimball A. Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data. BMJ Open. 2019, 9:e030579. 10.1136\/bmjopen-2019-030579","journal-title":"BMJ Open"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1159\/000431175","article-title":"Hidradenitis suppurativa\/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation","volume":"231","author":"Zouboulis CC","year":"2015","unstructured":"Zouboulis CC, Del Marmol V, Mrowietz U, Prens EP, Tzellos T, Jemec GB. Hidradenitis suppurativa\/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation. Dermatology. 2015, 231:184-90. 10.1159\/000431175","journal-title":"Dermatology"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.16691","article-title":"Hidradenitis suppurativa: advances in diagnosis and treatment","volume":"318","author":"Saunte DM","year":"2017","unstructured":"Saunte DM, Jemec GB. Hidradenitis suppurativa: advances in diagnosis and treatment. JAMA. 2017, 318:2019-32. 10.1001\/jama.2017.16691","journal-title":"JAMA"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00354-2","article-title":"Review of comorbidities of hidradenitis suppurativa: implications for daily clinical practice","volume":"10","author":"Tzellos T","year":"2020","unstructured":"Tzellos T, Zouboulis CC. Review of comorbidities of hidradenitis suppurativa: implications for daily clinical practice. Dermatol Ther (Heidelb). 2020, 10:63-71. 10.1007\/s13555-020-00354-2","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.4161\/derm.2.1.12490","article-title":"Comorbidities of hidradenitis suppurativa (acne inversa)","volume":"2","author":"Fimmel S","year":"2010","unstructured":"Fimmel S, Zouboulis CC. Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinol. 2010, 2:9-16. 10.4161\/derm.2.1.12490","journal-title":"Dermatoendocrinol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.01.014","article-title":"Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States","volume":"79","author":"Garg A","year":"2018","unstructured":"Garg A, Birabaharan M, Strunk A. Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States. J Am Acad Dermatol. 2018, 79:71-6. 10.1016\/j.jaad.2018.01.014","journal-title":"J Am Acad Dermatol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16677","article-title":"Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life","volume":"35","author":"Nguyen TV","year":"2021","unstructured":"Nguyen TV, Damiani G, Orenstein LA, Hamzavi I, Jemec GB. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol. 2021, 35:50-61. 10.1111\/jdv.16677","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.06.016","article-title":"All-cause mortality among patients with hidradenitis suppurativa: a population-based cohort study in the United States","volume":"81","author":"Reddy S","year":"2019","unstructured":"Reddy S, Strunk A, Garg A. All-cause mortality among patients with hidradenitis suppurativa: a population-based cohort study in the United States. J Am Acad Dermatol. 2019, 81:937-42. 10.1016\/j.jaad.2019.06.016","journal-title":"J Am Acad Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/93413-hidradenitis-suppurativa-in-the-united-states-insights-from-the-national-inpatient-sample-2008-2017-on-contemporary-trends-in-demographics-hospitalization-rates-chronic-comorbid-conditions-and-mortality","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:43Z","timestamp":1707507703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/93413-hidradenitis-suppurativa-in-the-united-states-insights-from-the-national-inpatient-sample-2008-2017-on-contemporary-trends-in-demographics-hospitalization-rates-chronic-comorbid-conditions-and-mortality"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,5]]},"references-count":44,"URL":"https:\/\/doi.org\/10.7759\/cureus.24755","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,5]]}}}